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Abstract
Background: A better understanding of the underlying mechanisms of DNA repair after low- and high-LET radiations 
represents a research priority aimed at improving the outcome of clinical radiotherapy. To date however, our 
knowledge regarding the importance of DNA DSB repair proteins and mechanisms in the response of human cells to 
high-LET radiation, is far from being complete.
Methods: We investigated the radiosensitizing effect after interfering with the DNA repair capacity in a human 
mammary epithelial cell line (MCF10A) by lentiviral-mediated RNA interference (RNAi) of the Ku70 protein, a key-
element of the nonhomologous end-joining (NHEJ) pathway. Following irradiation of control and Ku-deficient cell 
lines with either 6 MV X-rays or p(66)+Be(40) neutrons, cellular radiosensitivity testing was performed using a crystal 
violet cell proliferation assay. Chromosomal radiosensitivity was evaluated using the micronucleus (MN) assay.
Results: RNAi of Ku70 caused downregulation of both the Ku70 and the Ku80 proteins. This downregulation sensitized 
cells to both X-rays and neutrons. Comparable dose modifying factors (DMFs) for X-rays and neutrons of 1.62 and 1.52 
respectively were obtained with the cell proliferation assay, which points to the similar involvement of the Ku 
heterodimer in the cellular response to both types of radiation beams. After using the MN assay to evaluate 
chromosomal radiosensitivity, the obtained DMFs for X-ray doses of 2 and 4 Gy were 2.95 and 2.66 respectively. After 
neutron irradiation, the DMFs for doses of 1 and 2 Gy were 3.36 and 2.82 respectively. The fact that DMFs are in the 
same range for X-rays and neutrons confirms a similar importance of the NHEJ pathway and the Ku heterodimer for 
repairing DNA damage induced by both X-rays and p(66)+Be(40) neutrons.
Conclusions: Interfering with the NHEJ pathway enhanced the radiosensitivity of human MCF10A cells to low-LET X-
rays and high-LET neutrons, pointing to the importance of the Ku heterodimer for repairing damage induced by both 
types of radiation. Further research using other high-LET radiation sources is however needed to unravel the 
involvement of DNA double strand break repair pathways and proteins in the cellular response of human cells to high-
LET radiation.
Background
It is generally accepted that the effectiveness of ionizing
radiation depends on the quality of the radiation beam.
Densely ionizing, high-linear energy transfer (LET) types
of radiation are biologically more effective than sparsely
ionizing, low-LET types of radiation at inducing cell
lethality for a given absorbed dose. This increased effi-
ciency of inactivating cells by high-LET beams compared
to low-LET beams is usually described by the relative bio-
logical effectiveness (RBE).
Among the various types of DNA damage, DNA double
strand breaks (DSBs) are considered the most cytotoxic
lesions induced by ionizing radiation. As many types of
high-LET beams, including neutrons, in general do not
appear to induce more DSBs than low-LET radiation [1-
7], it seems likely that the differences in biological effect
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are associated with the type of DSBs induced by radia-
tions of differing LET and the mechanisms involved in
the processing of those DSBs. It has been described that
the degree of complexity of DNA DSBs and its possible
association with other types of damage varies depending
on the LET characteristics; therefore the biological
repairability of DSBs may vary with radiation type [3,8,9].
In mammalian cells, the homologous recombination
(HR) and nonhomologous end-joining (NHEJ) pathways
are identified as the two main mechanisms involved in
the repair of DSBs. The NHEJ pathway however is
regarded as the major pathway for the repair of radiation-
induced DSBs in mammalian cells [10,11]. One of the
key-players in this pathway is the Ku heterodimer, a
highly stable protein complex consisting of a 70 kDa and
a 86 kDa polypeptide, better known as Ku70 and Ku80
[12,13]. The importance of the Ku70 and Ku80 proteins
in DNA DSB repair after low-LET radiation is well dem-
onstrated by the profound enhancement in radiosensitiv-
ity of both Ku80-defective mutant rodent cell lines (e.g.
the xrs-5 and xrs-6 cell line) [14] and human cell lines
expressing reduced levels of the Ku proteins [15-23]. To
date however, the knowledge regarding the importance of
the Ku heterodimer and the NHEJ repair mechanism in
the cellular response to high-LET radiation, including
high energy neutrons, is limited and diverging results
were described when using cell survival as an endpoint to
analyze radiosensitivity [3,5,24-28]. In these reports, cel-
lular radiosensitivity was investigated in Ku-deficient
rodent cell lines with a wide variety of high-LET radiation
qualities (fast neutrons, α-particles, iron ions, carbon
ions). When the high-LET beams used had mean LET
values inferior to 100 keV/μm, the majority of these stud-
ies reported similar RBE values in the repair-deficient and
-proficient cell lines [3,5,24] pointing to an involvement
of the Ku protein in the repair of the radiation-induced
damage. When the radiation quality of the high-LET
beam was superior to 100 keV/μm, RBE values close to or
equal to 1 in repair-deficient cell lines were observed
[3,25-27], indicating no major involvement of the NHEJ
mechanism in the repair of high-LET radiation-induced
damage. However, contradictory observations [28] and
the lack of studies conducted with human Ku-deficient
cell lines suggests the importance of further research into
the biological mechanisms involved in the cellular
response to high-LET radiation, especially given the
growing interest and use of high-LET radiation in radio-
therapy [29,30].
In the present study, we investigated the role of the Ku
heterodimer in the repair of DNA lesions induced by
p(66)+Be(40) neutrons (mean LET ~20 keV/μm) and 6
MV X-rays. After knockdown of the Ku heterodimer by
lentiviral-mediated RNA interference (RNAi) of Ku70 in
a human mammary epithelial cell line (MCF10A), cellular
radiosensitivity was measured using a crystal violet cell
proliferation assay, while chromosomal radiosensitivity
was evaluated using the micronucleus (MN) assay.
Methods
Cell Culture
MCF10A cells, spontaneously immortalized human
breast epithelial cells, were cultured as monolayers in
DMEM/F12-Ham supplemented with 5% horse serum,
growth factors and antibiotics [23] in a humidified 5%
CO2 incubator at 37°C. To generate a repair-deficient cell
line, MCF10A cells were transduced with lentiviral parti-
cles harboring DNA sequences encoding for short hair-
pin RNA specific for Ku70 RNA interference (= Ku70i
cells). As a control cell line, MCF10A cells were mock-
transduced with 'empty' lentiviral particles (= LVTHM
cells). More details can be found in Vandersickel et al.
[23]. Protein expression silencing of Ku70 and Ku80 by
western blot analysis was evaluated in Ku70i and LVTHM
cells. When a stable knockdown was obtained, these cells
were used for all in vitro radiation experiments.
Radiation Experiments
Irradiation conditions
80% confluent cell cultures were trypsinized and plated at
appropriate densities 2 h prior to irradiation. Duplicate
cultures were irradiated at room temperature with either
6 MV X-rays or a clinical neutron beam which is pro-
duced by the reaction of 66 MeV protons on a Be target:
p(66)+Be(40) [31]. The neutrons produced in this beam
have a mean energy of 29 MeV and a mean LET of about
20 keV/μm. Within each experiment, one cell culture was
also sham irradiated.
Neutron exposures were performed using a vertical
beam directed downwards. Cultures were placed in a 29 ×
29 cm2 field on a 15 cm-thick backscatter block of per-
spex. Build-up material consisted of a 20 mm thick poly-
ethylene layer. Under these conditions the γ-component
in the beam is 6.9% and the total dose rate to the samples
was ~0.4 Gy/min. The neutron beam was calibrated using
a 0.5-cm3 tissue equivalent ionization chamber. The neu-
tron dose conformations at the irradiated position were
done as part of the routine quality control measures used
for daily radiation therapy.
X-ray irradiations were performed using a Philips SL
75-5 linear accelerator calibrated to use 6 MV X-rays. A
vertical treatment field of 30 cm × 30 cm was used to irra-
diate cell samples in multiwell plates or cell culture flasks.
A build-up plate of 20 mm polyethylene was used and cell
samples were placed on a block of 15 cm thick Perspex.
Crystal violet cell proliferation assay
As the colony forming ability of the LVTHM and Ku70i
cells was inadequate to quantify radiation-induced dam-Vandersickel et al. Radiation Oncology 2010, 5:30
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age, a cell proliferation method was used. Although the
crystal violet cell proliferative assay yield parameters dif-
ferent from that obtained with the classic colony forma-
tion assay, the crystal violet staining method has been
shown to reflect the relative radiosensitivities of different
cell lines [32]. For this assay, 2500 cells were seeded in 24-
well plates and exposed to doses ranging from 0 to 6 Gy
of X-rays or 0 to 3 Gy p(66)+Be(40) neutrons. Cells were
allowed to grow for several days until the control plates (0
Gy) nearly reached confluency. After fixation and stain-
ing with 0.01% crystal violet, optical density measure-
ments of extracted dye served as a measure of cell
growth. Cell survival at each dose point was expressed as
a percentage of the control survival rate [23,32].
Micronucleus assay
8 × 105 cells were seeded into T25 tissue culture flasks
and exposed to doses ranging from 0 to 6 Gy of X-rays or
0 to 3 Gy of p(66)+Be(40) neutrons. Cytochalasin B (2.25
μg/ml) was added immediately after irradiations to block
cytokinesis. Forty eight hours post-irradiation, cells were
harvested by trypsinization. Cell fixation, staining and
analysis of the samples were performed as previously
described [33]. Micronuclei were scored by light micros-
copy in 1000 binucleated (BN) cells.
Data analysis
Log cell surviving fractions (S) were fitted as a function of
radiation dose (D) to a linear-quadratic equation as
loge(S) = -αD - βD2 (Graphpad Prism 4 software). Radio-
sensitivities were expressed in terms of the mean inacti-
vation dose (MID). This parameter quantifies
radiosensitivity in a one-dimensional parameter with
units of dose (Gy). The mean inactivation dose is propor-
tional to the area under the survival curve. The ratio
MIDLVTHM/MIDKu70i represents the corresponding dose
modifying factor (DMF) and is used to evaluate the effect
of the Ku70/80 knockdown on cell survival. To compare
the effects of the radiation qualities (X-rays vs. neutrons),
the RBE of the neutron beam is defined by the ratio of
MIDX to the MIDn.
MN frequencies (Y) as a function of dose were best fit-
ted for both radiation qualities to a linear-quadratic
model Y = c+ αD+ βD2. The RBE generally used is given
by the ratio of the X-ray dose to the neutron dose to
obtain equal biological effects (iso-effect RBE). Because
of the slightly different shapes of the two linear quadratic
dose response curves, no single RBE value for fast neu-
trons with respect to X-rays, covering the whole dose
range, can be given. Therefore isoeffect RBE values have
been calculated for different doses by solving cX+ αXDX+
βXD2
X = cn + αnDn+ βnD2
n for DX and substituting the
result in the RBE expression [34]. This yields:
The DMF, to evaluate the effect of knocking down the
repair proteins Ku70 and Ku80 on MN formation, can be
calculated for different dose points in a similar way:
Results
Downregulation of the Ku heterodimer by RNAi of Ku70
W estern blot analysis confirms (Figure 1) that RNAi of
Ku70 causes a stable knockdown of the Ku70 protein. In
addition, a stable knockdown of the Ku80 subunit is also
observed. These findings are in agreement with several
independent reports showing that loss or decrease of one
of the subunits resulted in a significant decrease in the
steady state level of the other (for a review, see [23]). It
seems that each subunit is required to stabilize the other.
This is not unexpected in view of their function as a het-
erodimer in the NHEJ repair pathway [12,13].
Crystal violet cell proliferation assay
Our results (Figure 2, Table 1) show a dose dependent
decrease in cell survival, which is more pronounced in
the repair deficient Ku70i cell line. Radiosensitization is
observed for both X-rays (Figure 2A) and neutrons (Fig-
ure 2B). After X-ray irradiation, the mean inactivation
dose decreased from 3.60 Gy for the mock-transduced
LVTHM cells to 2.22 Gy for the Ku70i cells, resulting in a
DMF of 1.62. After neutron irradiation, a decrease in the
mean inactivation dose of 1.74 Gy for the LVTHM cells to
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Figure 1 Western blot of MCF10A cells after RNAi of Ku70. Protein 
expression levels of the Ku70 and the Ku80 protein are shown in both 
the LVTHM (control cell line) and Ku70i (RNAi of Ku70) cell line. Actin 
was used as a protein loading control. RNAi of Ku70 caused downreg-
ulation of both the Ku70 and the Ku80 proteins.
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1.14 Gy for the Ku70i cells is observed. This represents a
DMF of 1.52.
The RBE of the neutron beam observed with LVTHM
cells, calculated using the ratio of the mean inactivation
doses for X-rays and neutrons, is 2.07. The resulting RBE
for the Ku70i cells is very similar (1.95).
Micronucleus assay
Dose response curves obtained after X-ray and neutron
exposure show a dose dependent linear quadratic
increase in micronuclei frequencies for both the Ku70i
and LVTHM cell lines (Figure 3, Table 2). At each dose a
higher MN yield was observed for the Ku70i cells com-
pared to the mock-transduced LVTHM cells and this for
Table 1: Survival parameters and MID for LVTHM and Ku70i MCF10A cells following exposure to neutrons and X-rays.
Radiation type αβMID
p(66)+Be(40) neutrons LVTHM 0.33 0.097 1.74
Ku70i 0.60 0.161 1.14
X-rays LVTHM 0.07 0.043 3.60
Ku70i 0.19 0.083 2.22
Figure 2 Cell survival curves after exposure of Ku70i and LVTHM MCF10A cells to X-ray doses ranging from 0 to 6 Gy or neutron doses from 
0 to 3 Gy. Cell survival was measured using a crystal violet cell proliferation assay. Log surviving fractions were fitted as a function of dose using the 
linear quadratic equation. Each data point represents the mean ± SEM of 4 experiments. (A) and (B) show the effect of Ku70/80 knockdown on cell 
survival for X-rays and neutrons respectively. In (C) and (D) a comparison of the effect of the radiation qualities in cells with wild type levels (LVTHM 
cells) and lower expression levels of Ku70/80 (Ku70i cells) respectively, is presented.
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both types of radiation. The DMFs, calculated for X-ray
doses of 2 and 4 Gy are 2.95 and 2.66 respectively. After
neutron irradiation, the DMFs for doses of 1 and 2 Gy are
respectively 3.36 and 2.82.
Calculated RBE values for a neutron dose of 1 and 2 Gy
are 2.07 and 2.16 for the LVTHM cells. For the Ku70i cells
RBE values of 2.67 and 2.5 respectively are obtained.
Discussion
Although an enhancement in radiosensitivity to low-LET
radiation in Ku-deficient cells is well described, less is
known about the effects of Ku-deficiency in the cellular
response of human cells after exposure to high-LET radi-
ation. In the present study, we investigated the role of the
Ku heterodimer in the response of human breast epithe-
lial MCF10A cells after exposure to 6 MV X-rays and
p(66)+Be(40) neutrons. To this aim, cellular and chromo-
somal radiosensitivity were assessed in a control
MCF10A cell line, and in a Ku70-knockdown derivative
subline, obtained by RNA interference of Ku70.
The cell proliferation assay, used to assess cellular radi-
osensitivity, showed a RBE value of 2.07 in mock-trans-
duced LVTHM cells. This finding, in agreement with
other literature data [32,35], demonstrates that
p(66)+Be(40) neutrons are indeed more effective per unit
absorbed dose than X-rays in inactivating cell prolifera-
tion. A similar RBE value of 1.95 was found for repair
deficient Ku70i cells, indicating a similar effectiveness of
this neutron beam relative to X-rays with respect to inac-
tivating cell proliferation in both repair-proficient and -
deficient cell lines.
Marked differences observed in the cellular radiation
response between the mock-transduced LVTHM and
Ku70i cells further implicate that a partial knockdown of
Ku results in an increase in radiosensitivity and this for
both radiation qualities. DMFs of 1.62 and 1.52 were
recorded following treatment with both 6 MV X-rays and
p(66)+Be(40) neutrons, respectively. Interestingly, the
observation that DMFs for both radiation treatment
m o d a l i t i e s  w e r e  c o m p a r a b l e  d e m o n s t r a t e s  t h a t  t h e  K u
heterodimer is as important for repairing radiation dam-
Figure 3 Dose response curves of # MN/1000 BN cells after exposure of Ku70i and LVTHM MCF10A cells to X-ray doses ranging from 0 to 6 
Gy or neutron doses from 0 to 3 Gy. MN frequencies (Y) as a function of dose (D) were fitted to a linear-quadratic model Y = c+ αD+ βD2. Each data 
point represents the mean ± SEM of 2 experiments. The number of micronuclei at doses of 2 and 4 Gy X-rays and doses of 1 and 2 Gy neutrons rep-
resents the mean ± SEM of 9 experiments. (A) and (B) show the effect of Ku70/80 knockdown on MN formation for X-rays and neutrons respectively. 
In (C) and (D) a comparison of the effect of the radiation qualities in cells with wild type levels (LVTHM cells) and lower expression levels of Ku70/80 
(Ku70i cells) respectively, is presented.
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age induced by 6 MV X-rays (mean LET < 1 keV/μm) and
p(66)+Be(40) neutrons (mean LET ~20 keV/μm).
The MN assay was performed to assess chromosomal
radiosensitivity in our cell model. Micronuclei are pre-
dominantly acentric chromosomal fragments resulting
mainly from misrepaired DNA DSBs by the NHEJ path-
way [36]. Results obtained with the MN assay in this
study, showing DMFs that are in the same range for both
neutrons and X-rays, confirm a similar importance of the
NHEJ pathway and the Ku heterodimer for repairing
DNA damage induced by both X-rays and high energy
neutrons.
In summary, as the average LET of p(66)+Be(40) neu-
trons is about 20 keV/μm, these results are supporting the
hypothesis of Britten et al. [3] who argued that several
components of the DNA sensing/repair machinery may
be of major relevance for the cellular response to low-
LET as well as high-LET radiation when the latter have a
mean LET value inferior to 100 keV/μm, while they
would be of less importance for the repair of more com-
plex lesions induced by radiation with LET values supe-
rior to 100 keV/μm. Because this hypothesis was based on
data derived from experiments with Ku-defective rodent
cell lines, our results give a first indication that the con-
clusions of Britten et al. may be extended to human cell
lines. However, additional research using high-LET radia-
tion beams with differing LET values is required to draw
more general conclusions.
In addition, our findings are also interesting in the
frame of the clinical use of both low- and high-LET radia-
tion beams, such as clinical neutron [30] and carbon ion
beams [29]. Despite recent remarkable progress in the
efficacy of radiotherapy, cellular resistance to radiother-
apy is still a significant component of tumor treatment
failure. The ability to repair DNA damage is probably the
most important determinant of resistance to ionizing
radiation [37]. Therefore, reduction of the capacity of
tumor cells to repair DSBs through targeted gene therapy
mediated inactivation of DSB repair proteins may repre-
sent a promising strategy to enhance radioresponsiveness
of neoplastic tissues and to increase radiation-induced
tumor eradication rates [38,39].
Conclusions
Our results show that partial knockdown of Ku, one of
the key proteins involved in the NHEJ pathway for DNA
DSB repair, enhances the radiosensitivity of human
MCF10A cells to both 6 MV X-rays and p(66)+Be(40)
neutrons. Dose modifying factors are very similar, irre-
spective of radiation quality, which demonstrates the
importance of the Ku heterodimer for repairing radiation
damage induced by both low-LET X-rays and high energy
neutrons. Although additional research is required, these
results provide evidence that selective modulation of the
repair capacity of cells in tumor and normal tissues may
represent a future strategy to enhance the effects of
radiotherapy using X-rays or high energy neutrons. These
results may also be equally applicable to carbon ion ther-
apy, that is currently under development in both Europe
and Japan [29].
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Table 2: Fitted linear quadratic coefficients for neutrons and X-rays obtained after MN evaluation in LVTHM and Ku70i 
MCF10A cells.
Radiation type αβc*
p(66)+Be(40) neutrons LVTHM 23.54 7.08 6.33
Ku70i 124.5 24.29 16.65
X-rays LVTHM 12.36 1.17 6.33
Ku70i 39.89 5.88 16.65
* c values represent spontaneous number of MN/1000 BN cellsVandersickel et al. Radiation Oncology 2010, 5:30
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